Cargando…
De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
COVID 19 pandemic represents an emergency for public health services and containment measures to reduce the risk of infection have been promptly activated worldwide. The healthcare systems reorganization has had a major impact on the management of cancer patients who are considered at high risk of i...
Autores principales: | Fedele, Palma, Sanna, Valeria, Fancellu, Alessandro, Marino, Antonella, Calvani, Nicola, Cinieri, Saverio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672334/ https://www.ncbi.nlm.nih.gov/pubmed/33254036 http://dx.doi.org/10.1016/j.critrevonc.2020.103148 |
Ejemplares similares
-
The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review
por: Marta, Gustavo Nader, et al.
Publicado: (2020) -
Can mHealth interventions improve quality of life of cancer patients? A systematic review and meta-analysis
por: Buneviciene, Inesa, et al.
Publicado: (2021) -
Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective
por: Bakhribah, Hatoon, et al.
Publicado: (2020) -
Telemedicine and the current opportunities for the management of oncological patients in Peru in the context of COVID-19 pandemic
por: Montenegro, Paola, et al.
Publicado: (2021) -
A proposal of a “ready to use” COVID-19 control strategy in an Oncology ward: Utopia or reality?
por: Dalu, Davide, et al.
Publicado: (2021)